Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 6,239.88 | 272.36 | 292.28¢ | 18.1 | 3.5 | +5% | 443.73¢ | 8.4% |
| 31-Dec-13 | 6,359.13 | 315.65 | 332.50¢ | 15.9 | 1.2 | +14% | 456.27¢ | 8.6% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
| HGS to Test Lupus Drug as MS Treatment | 29-May-2008 | Washington Post |
| Currency | US Dollars |
| Share Price | $ 52.94 |
| Change Today | $ 0.46 |
| % Change | 0.88 % |
| 52 Week High | $65.99 |
| 52 Week Low | $51.31 |
| Volume | 150,253 |
| Shares Issued | 70.76m |
| Market Cap | $3,745.83m |
| Beta | 0.37 |
| RiskGrade | 104 |
| Strong Buy | 1 |
| Buy | 1 |
| Neutral | 9 |
| Sell | 1 |
| Strong Sell | 2 |
| Total | 14 |

| Time | Volume / Share Price |
| 16:18 | 7,551 @ $52.94 |
| 16:14 | 254 @ $52.94 |
| 16:14 | 100 @ $52.94 |
| 16:14 | 100 @ $52.93 |
| 16:14 | 100 @ $52.92 |
You are here: research